It’s a good, high quality, large sized asset,” said Munjal.“The problem is nobody has put money directly into the company so far. All the offers that have come in so far are to restructure (Fortis)…this is why our offer becomes far superior,” he said. And how many times has anything happened instantaneously?” he said, adding this process could take as long as 18 months.“What is the company (Fortis) going to do for funds until then?” he said. According to him, if the operations of Fortis take a financial hit during this time, the quality of its services will drop. “I don’t have to explain what happens to the shareholders after that,” he added.According to the Burmans, who have experience in the oncology segment through Dabur Pharma, Fortis is an “undervalued” asset.“And to replicate an asset like this?

Source: Economic Times April 13, 2018 16:30 UTC